These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8105201)
21. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
22. [Variations in hemostasis and fibrinolysis during the treatment of acute myocardial infarct (AMI) with tissue-type plasminogen activator (TTPA). A study of 17 cases]. Izaguirre Avila R; Ruiz de Chávez Cervantes A; Villavicencio R; Gómez Trigos A; Mar Chavira R; Spíndola Mdel C; Casanova JM Arch Inst Cardiol Mex; 1993; 63(3):235-40. PubMed ID: 8347053 [TBL] [Abstract][Full Text] [Related]
23. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration. Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824 [TBL] [Abstract][Full Text] [Related]
24. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis]. Motomiya T Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012 [No Abstract] [Full Text] [Related]
26. How should intravenous thrombolytic agents for acute myocardial infarction be selected? Topol EJ Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103 [No Abstract] [Full Text] [Related]
27. [Clinical application of intravenous thrombolytic therapy in acute myocardial infarction]. Kanmatsuse K; Kajiwara N Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1213-7. PubMed ID: 1431461 [No Abstract] [Full Text] [Related]
28. Correlation between D-dimer levels and coronary artery reperfusion in acute myocardial infarction patients after thrombolytic treatment. Cakar MA; Gunduz H; Varim C; Ozdemir F; Vatan MB; Akdemir R Blood Coagul Fibrinolysis; 2013 Sep; 24(6):608-12. PubMed ID: 23917585 [TBL] [Abstract][Full Text] [Related]
29. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator. Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203 [TBL] [Abstract][Full Text] [Related]
30. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy]. Chernetsov VA Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019 [No Abstract] [Full Text] [Related]
31. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA]. De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587 [TBL] [Abstract][Full Text] [Related]
32. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?]. Meyer D; Tsakiris DA; Marbet GA Schweiz Med Wochenschr; 1989 Sep; 119(39):1352-4. PubMed ID: 2678451 [TBL] [Abstract][Full Text] [Related]
35. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture]. Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195 [TBL] [Abstract][Full Text] [Related]
36. Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone. Réganon E; Ferrando F; Vila V; Villa P; Martínez-Sales V; Fayos L; Ruano M; Aznar J Haemostasis; 1998; 28(2):99-105. PubMed ID: 10087435 [TBL] [Abstract][Full Text] [Related]
37. Diphasic increase in thrombin-antithrombin III complex in blood from the internal jugular vein following severe head injury. Suzuki M; Motohashi O; Nishino A; Shiina V; Mizoi K; Yoshimoto T; Kameyama M; Onuma T Thromb Haemost; 1994 Jan; 71(1):155-7. PubMed ID: 8165638 [No Abstract] [Full Text] [Related]
38. [Thrombolytic therapy with tissue-type plasminogen activator]. Toma M; Yamaguchi T Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618 [No Abstract] [Full Text] [Related]
39. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase]. Bai XJ; Chen CX; He YL Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371 [TBL] [Abstract][Full Text] [Related]
40. Prothrombin fragment 1 + 2 and thrombin-antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation. Monteagudo J; Reverter JC; Pereira A; Pijoan J; Balust J; Escolar G; Mazzara R; Taurá P; Visa J; Ordinas A Haemostasis; 1993; 23(1):51-7. PubMed ID: 8477908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]